Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial

被引：0
|
作者：
Renata Ferrarotto
Luana G. Sousa
Yun Qing
Diana Kaya
Bettzy Stephen
Dipti Jain
Diana Bell
Shubham Pant
Apostolia M. Tsimberidou
Filip Janku
George Blumenschein
Bonnie S. Glisson
Jordi Rodon Ahnert
Sarina A. Piha-Paul
J. Jack Lee
Michael K. Wong
Charles Lu
Funda Meric-Bernstam
Aung Naing
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Thoracic/Head and Neck Medical Oncology
[2] The University of Texas MD Anderson Cancer Center,Department of Biostatistics
[3] The University of Texas MD Anderson Cancer Center,Department of Radiology
[4] The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics
[5] The University of Texas MD Anderson Cancer Center,Department of Pathology
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Pembrolizumab; Checkpoint inhibitor; Rare cancers; Cutaneous squamous cell carcinoma; Skin cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4581 / 4591
页数：10
相关论文
共 50 条
  • [1] Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial
    Ferrarotto, Renata
    Sousa, Luana G.
    Qing, Yun
    Kaya, Diana
    Stephen, Bettzy
    Jain, Dipti
    Bell, Diana
    Pant, Shubham
    Tsimberidou, Apostolia M.
    Janku, Filip
    Blumenschein, George
    Glisson, Bonnie S.
    Ahnert, Jordi Rodon
    Piha-Paul, Sarina A.
    Lee, J. Jack
    Wong, Michael K.
    Lu, Charles
    Meric-Bernstam, Funda
    Naing, Aung
    ADVANCES IN THERAPY, 2021, 38 (08) : 4581 - 4591
  • [2] Phase II trial of pembrolizumab (MK-3475) in metastatic cutaneous squamous cell carcinoma (cSCC)
    Kudchadkar, Ragini Reiney
    Yushak, Melinda Lynne
    Lawson, David H.
    Delman, Keith A.
    Lowe, Michael C.
    Goings, Monica
    McBrien, Stephanie
    Mckellar, Marjorie
    Sieja, Kristin
    Maynard, Necia
    Ford, Mandy
    Pollack, Brian P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Efficacy of pembrolizumab in patients with cutaneous squamous cell carcinoma
    Ferrarotto, R.
    Glisson, B.
    Blumenschein, G.
    Hong, D.
    Piha-Paul, S.
    Ahnert, J. Rodon
    Pant, S.
    Tsimberidou, A.
    Janku, F.
    Alshawa, A.
    Jain, D.
    Rejon, M.
    Hess, K.
    Colen, R.
    Lu, C.
    Stephen, B.
    Tapia, C.
    Mendoza, T.
    Meric-Bernstam, F.
    Naing, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E75 - E75
  • [4] Phase II trial of pembrolizumab (MK-3475) in metastatic cutaneous squamous cell carcinoma: An updated analysis.
    Yushak, Melinda Lynne
    Lawson, David H.
    Goings, Monica
    Mckellar, Marjorie
    Maynard, Necia
    Woodruff, Kristin Sieja
    Gorgoglione, Caroline
    McBrien, Stephanie
    Delman, Keith A.
    Lowe, Michael C.
    Kudchadkar, Ragini Reiney
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Pembrolizumab in patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC): The phase II KEYNOTE-629 study
    Licitra, L. F.
    Siu, L. L.
    Cohen, E. E. W.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Harrington, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] KEYNOTE-629: Phase 2 trial of pembrolizumab in patients (pts) with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC)
    Licitra, L.
    Siu, L.
    Cohen, E.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Harrington, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)
    Grob, Jean-Jacques
    Gonzalez, Rene
    Basset-Seguin, Nicole
    Vornicova, Olga
    Schachter, Jacob
    Joshi, Abhishek
    Meyer, Nicolas
    Grange, Florent
    Piulats, Josep M.
    Bauman, Jessica R.
    Zhang, Pingye
    Gumuscu, Burak
    Swaby, Ramona F.
    Hughes, Brett G. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (25) : 2916 - +
  • [8] A phase II trial of pembrolizumab and cabozantinib in patients (pts) with recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC).
    Saba, Nabil F.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Patel, Mihir
    Schmitt, Nicole Cherie
    Stokes, William A.
    Bates, James Edward
    Rudra, Soumon
    Abousaud, Marin Ibrahim
    Muzaffar, Jameel
    Kirtane, Kedar
    Teng, Yong
    Steuer, Conor Ernst
    Shin, Dong Moon
    Liu, Yuan
    Chung, Christine H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Gefitinib for advanced cutaneous squamous cell carcinoma of head and neck: Phase II trial
    Weber, R. S.
    Lustig, R. A.
    El-Naggar, A. K.
    Rosenthal, D. I.
    Kim, E. S.
    Wistuba, I. I.
    Tang, X. M.
    Wan, F. F.
    Taylor, S. A.
    Glisson, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Treatment of unresectable cutaneous squamous cell carcinoma with pembrolizumab
    Venkatesh, Samantha
    Al-Haseni, Ali
    Sahni, Debjani
    BMJ CASE REPORTS, 2019, 12 (08)
12345